Outsmarting Multi-Drug Resistance in Uncertain Times

Outsmarting Multi-Drug Resistance in Uncertain Times is organized by ProCE, Inc. and will be held from Feb 01, 2019 - Feb 01, 2022.

Accreditation:
Pharmacists
This activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for  1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers.

Course Description:
Prior to the development of reversal agents for direct oral anticoagulants (DOACs), pharmacists and clinicians were left with little choice in managing acute major bleeding. Assessment of the severity of the bleed is a one of the first steps in determining if reversal of anticoagulation is necessary. After other initial measures are completed, should the clinician determine reversal to remain necessary, the decision on which reversal agent to use becomes critical. Fortunately, specific treatments have been developed to address this need and new data is continually becoming available to aid in the selection process.

Learning Objectives:
The target audience for this activity includes infectious disease pharmacists and other health?system pharmacists, including chief pharmacy officers and pharmacy directors. At the completion of this symposium, the participant will be better able to:
• Describe the changing epidemiology and clinical implications of multi-drug resistant infections.
• Review new treatment approaches with current antibiotics, along with their limitations, in the setting of significant antibiotic resistance.
• Compare and contrast new and emerging antimicrobial agents for gram-positive and gram-negative infections, alongside existing antibiotics, to help direct optimal selection of therapy in clinical practice.
• Review antimicrobial stewardship interventions for the use of new antimicrobial agents and strategies to measure the outcomes.